Prescription Drugs Market Research Reports & Industry Analysis
The prescription drugs industry is a key cornerstone of healthcare, delivering vital medications that improve and save lives. As this industry continues to evolve, understanding its nuances can be an ongoing challenge. MarketResearch.com provides hundreds of authoritative prescription drugs market research reports to help stakeholders understand the shifting market landscape and devise effective business strategies.
The Latest Prescription Drugs Market Analysis
- We provide data-packed reports on a wide range of product types, therapeutic areas, regions, and companies.
- Our research includes in-depth analyses of prescription drug market size, growth forecasts, and drivers and challenges.
- In addition, we cover the rise of personalized medicine and gene therapies, as well as regulatory issues and pricing models.
Your Dedicated Research Partner
As the prescription drugs industry shifts and changes, MarketResearch.com equips you with the tools to thrive. Trusted for decades as a reliable research partner, our clients include top pharmaceutical companies, investment banks, and universities. Whether you are exploring new markets or seeking to futureproof your business, our prescription drugs industry research reports offer a wealth of knowledge to inform your strategy. Get started by exploring our vast selection of reports on the prescription drugs industry today.
Prescription Drugs Industry Research & Market Reports
-
Global Pain Management Drugs & Devices Market Growth 2023-2029
... Devices sales in 2022, providing a comprehensive analysis by region and market sector of projected Pain Management Drugs & Devices sales for 2023 through 2029. With Pain Management Drugs & Devices sales broken down by ... Read More
-
Global Insomnia Pharmacological Treatment Market Growth (Status and Outlook) 2023-2029
... 2022, providing a comprehensive analysis by region and market sector of projected Insomnia Pharmacological Treatment sales for 2023 through 2029. With Insomnia Pharmacological Treatment sales broken down by region, market sector and sub-sector, this report ... Read More
-
ENSPRYNG Emerging Drug Insight and Market Forecast − 2032
... detailed picture of the ENSPRYNG for generalized myasthenia gravis in the 7MM, i.e., the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan for the study period 2019 –2032 is ... Read More
-
Bimekizumab Emerging Drug Insight and Market Forecast – 2032
... the Bimekizumab for Hidradenitis Suppurativa in the 7MM, i.e., the United States, EU4 (Germany, France, Italy, and Spain) and the UK, and Japan, for the study period 2019–2032 is provided in this report along with ... Read More
-
COSENTYX Emerging Drug Insight and Market Forecast – 2032
... the COSENTYX for Hidradenitis Suppurativa in the 7MM, i.e., the United States, EU4 (Germany, France, Italy, and Spain) and the UK, and Japan, for the study period 2019–2032 is provided in this report along with ... Read More
-
2023 Global Forecast for Oral contraceptive preparations (2024-2029 Outlook)-Manufacturing & Markets Report
... Estimates on equipment or material sales (product shipments value) are published historically for 2016 to 2020, projections for 2021 to 2023 and forecasts for 2024 to 2029. Product shipments include the total value of all ... Read More
-
2023 Global Forecast for Prescription sedatives and hypnotics, barbiturates (2024-2029 Outlook)-Manufacturing & Markets Report
... 40 countries. Estimates on equipment or material sales (product shipments value) are published historically for 2016 to 2020, projections for 2021 to 2023 and forecasts for 2024 to 2029. Product shipments include the total value ... Read More
-
2023 Global Forecast for Antihistamine cold preparations, prescription (2024-2029 Outlook)-Manufacturing & Markets Report
... countries. Estimates on equipment or material sales (product shipments value) are published historically for 2016 to 2020, projections for 2021 to 2023 and forecasts for 2024 to 2029. Product shipments include the total value of ... Read More
-
Nipocalimab Emerging Drug Insight and Market Forecast − 2032
... detailed picture of the nipocalimab for generalized myasthenia gravis in the 7MM, i.e., the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan for the study period 2019 –2032 is ... Read More
-
UPLIZNA Emerging Drug Insight and Market Forecast − 2032
... detailed picture of the UPLIZNA for generalized myasthenia gravis in the 7MM, i.e., the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan for the study period 2019 –2032 is ... Read More
-
Povorcitinib (INCB054707) Emerging Drug Insight and Market Forecast – 2032
... detailed picture of the Povorcitinib (INCB054707) for Hidradenitis Suppurativa in the 7MM, i.e., the United States, EU4 (Germany, France, Italy, and Spain) and the UK, and Japan, for the study period 2019–2032 is provided in ... Read More
-
Latozinemab (AL001) Emerging Drug Insight and Market Forecast – 2032
... detailed picture of the Latozinemab (AL001) for Frontotemporal dementia in the 7MM, i.e., the United States, EU4 (Germany, France, Italy, and Spain) and the UK, and Japan, for the study period 2019–2032 is provided in ... Read More
-
Osteoarthritis Market Size, Share, and Analysis, By Type (Hip Osteoarthritis, Knee Osteoarthritis, Foot & Ankle Osteoarthritis, Shoulder Osteoarthritis, Spinal Osteoarthritis), By Drug Type (Analgesics, Corticosteroids, Viscosupplementation agents, Nonsteroidal anti-inflammatory drugs {NSAIDS}), By Diagnosis (Imagining and Joint Fluid Analysis), By Route of Administration (Parenteral Route, Oral Route, Topical Route), By Treatment (Medication, Therapy, Surgery), By Distribution Channel (Hospitals Pharmacy, E-Commerce, Retail Pharmacy, Drug Store), By Purchasing Pattern (Prescription Drugs, Over-The-Counter Drugs) and Regional Forecasts, 2022-2032
... Joint Fluid Analysis), By Route of Administration (Parenteral Route, Oral Route, Topical Route), By Treatment (Medication, Therapy, Surgery), By Distribution Channel (Hospitals Pharmacy, E-Commerce, Retail Pharmacy, Drug Store), By Purchasing Pattern (Prescription Drugs, Over-The-Counter Drugs) ... Read More
-
Hearing Loss Disease Treatment Market Share, Size, Trends, Industry Analysis Report, By Product (Devices, Drugs); By Disease Type; By End-User; By Region; Segment Forecast, 2023 - 2032
... is expected treach USD 19.99 billion by 2032, according ta new study by Polaris Market Research. The report “Hearing Loss Disease Treatment Market Share, Size, Trends, Industry Analysis Report, By Product (Devices, Drugs); By Disease ... Read More
-
Zilucoplan Emerging Drug Insight and Market Forecast − 2032
... detailed picture of the zilucoplan for generalized myasthenia gravis in the 7MM, i.e., the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan for the study period 2019 –2032 is ... Read More
-
Tuberculosis Treatment Drugs Market By Disease Type (Active Tuberculosis, Latent Tuberculosis), By Therapy Type (First Line Therapy, Second Line Therapy), By Distribution Channel (Hospital Pharmacies, Drug Stores and Retail Pharmacies, Online Providers): Global Opportunity Analysis and Industry Forecast, 2021-2031
... and Industry Forecast, 2021-2031 The Tuberculosis Treatment Drugs Market valued for $1,929.96 million in 2021 and is estimated to reach $3,243.90 million by 2031, exhibiting a CAGR of 5.3% from 2022 to 2031. Tuberculosis (TB) ... Read More
-
ULTOMIRIS Market Drug Insight and Market Forecast − 2032
... detailed picture of the ULTOMIRIS for generalized myasthenia gravis in the 7MM, i.e., the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan for the study period 2019 –2032 is ... Read More
-
2023 Global Forecast for Cough and cold combinations, prescription (2024-2029 Outlook)-Manufacturing & Markets Report
... 40 countries. Estimates on equipment or material sales (product shipments value) are published historically for 2016 to 2020, projections for 2021 to 2023 and forecasts for 2024 to 2029. Product shipments include the total value ... Read More
-
2023 Global Forecast for Vasodilators, ace inhibitors (2024-2029 Outlook)-Manufacturing & Markets Report
... Estimates on equipment or material sales (product shipments value) are published historically for 2016 to 2020, projections for 2021 to 2023 and forecasts for 2024 to 2029. Product shipments include the total value of all ... Read More
-
Batoclimab Emerging Drug Insight and Market Forecast − 2032
... detailed picture of the batoclimab for generalized myasthenia gravis in the 7MM, i.e., the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan for the study period 2019 –2032 is ... Read More
-
TAVNEOS (Avacopan) Emerging Drug Insight and Market Forecast – 2032
... detailed picture of the TAVNEOS (Avacopan) for Hidradenitis Suppurativa in the 7MM, i.e., the United States, EU4 (Germany, France, Italy, and Spain) and the UK, and Japan, for the study period 2019–2032 is provided in ... Read More
-
Zunsemetinib (ATI-450) Emerging Drug Insight and Market Forecast – 2032
... detailed picture of the Zunsemetinib (ATI-450) for Hidradenitis Suppurativa in the 7MM, i.e., the United States, EU4 (Germany, France, Italy, and Spain) and the UK, and Japan, for the study period 2019–2032 is provided in ... Read More
-
The U.S. Weight Loss & Diet Control Market
... Covid-19 pandemic and recession. The big story of 2022 has been the soaring demand for new obesity drugs such as Wegovy and Saxenda, with more new drugs coming soon. The market may be entering a ... Read More
-
Rozanolixizumab Emerging Drug Insight and Market Forecast − 2032
... detailed picture of the rozanolixizumab for generalized myasthenia gravis in the 7MM, i.e., the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan for the study period 2019 –2032 is ... Read More
-
Haleon Plc in Consumer Health (World)
... a key region, Asia Pacific, and the Middle East and Africa have provided significant gains.. As Rx-to-OTC switches dry up, Haleon will continue to look for strategic investments to grow inorganically. There are opportunities to ... Read More
Research Assistance
